Adamax is an advanced next-generation analog of Semax, engineered with two key structural modifications: N-acetyl protection at the N-terminus and the addition of an adamantane group. These modifications give Adamax significantly enhanced stability, improved blood-brain barrier penetration, and a longer duration of action compared to standard Semax.
The adamantane group confers greater resistance to enzymatic degradation and increases the peptide’s lipophilicity – the same mechanism seen in P21. The result is a more durable, more bioavailable version of the Semax scaffold, designed for sustained neurological research applications.
Adamax is studied for its influence on BDNF (brain-derived neurotrophic factor) signaling, TrkB receptor expression, neurogenesis, synaptic plasticity, and cognitive resilience under physiological stress. Researchers investigating neuroprotection, learning and memory formation, and focus and attention regulation have shown interest in this compound.
For Research Use Only. Not for human consumption. This product is intended solely for in vitro research and laboratory use.
